<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE root>
<article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:ali="http://www.niso.org/schemas/ali/1.0/" article-type="other" dtd-version="1.2" xml:lang="en"><front><journal-meta><journal-id journal-id-type="publisher-id">Russian Military Medical Academy Reports</journal-id><journal-title-group><journal-title xml:lang="en">Russian Military Medical Academy Reports</journal-title><trans-title-group xml:lang="ru"><trans-title>Известия Российской Военно-медицинской академии</trans-title></trans-title-group></journal-title-group><issn publication-format="print">2713-2315</issn><issn publication-format="electronic">2713-2323</issn><publisher><publisher-name xml:lang="en">Eco-Vector</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="publisher-id">716543</article-id><article-id pub-id-type="doi">10.17816/rmmar716543</article-id><article-categories><subj-group subj-group-type="toc-heading" xml:lang="en"><subject>Original articles</subject></subj-group><subj-group subj-group-type="toc-heading" xml:lang="ru"><subject>Оригинальные исследования</subject></subj-group><subj-group subj-group-type="article-type"><subject>Unknown</subject></subj-group></article-categories><title-group><article-title xml:lang="en">Prevalence and risk factors of cognitive disorders in patients on maintenance hemodialysis</article-title><trans-title-group xml:lang="ru"><trans-title>Распространенность и факторы риска когнитивных расстройств у больных на программном гемодиализе</trans-title></trans-title-group><trans-title-group xml:lang="zh"><trans-title/></trans-title-group></title-group><contrib-group><contrib contrib-type="author"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0002-3045-1721</contrib-id><contrib-id contrib-id-type="spin">6337-6039</contrib-id><name-alternatives><name xml:lang="en"><surname>Shcherbakov</surname><given-names>Evgeniy V.</given-names></name><name xml:lang="ru"><surname>Щербаков</surname><given-names>Евгений Вячеславович</given-names></name><name xml:lang="zh"><surname></surname><given-names></given-names></name></name-alternatives><address><country country="RU">Russian Federation</country></address><bio xml:lang="en"><p>nephrologist, nephrology and blood purification department </p></bio><bio xml:lang="ru"><p>врач-нефролог, клиника нефрологии и эфферентной терапии </p></bio><email>evgenvmeda@mail.ru</email><xref ref-type="aff" rid="aff1"/></contrib><contrib contrib-type="author"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0002-5893-3191</contrib-id><contrib-id contrib-id-type="spin">5572-8891</contrib-id><name-alternatives><name xml:lang="en"><surname>Pyatchenkov</surname><given-names>Mikhail O.</given-names></name><name xml:lang="ru"><surname>Пятченков</surname><given-names>Михаил Олегович</given-names></name><name xml:lang="zh"><surname></surname><given-names></given-names></name></name-alternatives><address><country country="RU">Russian Federation</country></address><bio xml:lang="en"><p>Grand PhD in Medical sciences, senior lecturer, nephrology and blood purification department</p></bio><bio xml:lang="ru"><p>доктор. мед. наук, старший преподаватель, кафедра нефрологии и эфферентной терапии</p></bio><email>pyatchenkovMD@yandex.ru</email><xref ref-type="aff" rid="aff1"/></contrib><contrib contrib-type="author"><contrib-id contrib-id-type="orcid">https://orcid.org/0009-0005-2027-1590</contrib-id><contrib-id contrib-id-type="spin">4443-0635</contrib-id><name-alternatives><name xml:lang="en"><surname>Doroshuk</surname><given-names>Ksenia S</given-names></name><name xml:lang="ru"><surname>Дорощук</surname><given-names>Ксения Сергеевна</given-names></name><name xml:lang="zh"><surname></surname><given-names></given-names></name></name-alternatives><address><country country="RU">Russian Federation</country></address><bio xml:lang="en"><p>therapist, nephrology and blood purification department</p></bio><bio xml:lang="ru"><p>врач-терапевт, клиника нефрологии и эфферентной терапии</p></bio><email>vmeda_12@mil.ru</email><xref ref-type="aff" rid="aff1"/></contrib></contrib-group><aff-alternatives id="aff1"><aff><institution xml:lang="en">Federal state budgetary military educational institution of high education “Military medical academy named after S.M. Kirov” of Russian Ministry of defense, St. Petersburg, Russia</institution></aff><aff><institution xml:lang="ru">Федеральное государственное бюджетное военное образовательное учреждение высшего образования «Военно-медицинская академия имени С.М. Кирова» Министерства обороны Российской Федерации, Санкт-Петербург, Российская Федерация</institution></aff><aff><institution xml:lang="zh"></institution></aff></aff-alternatives><pub-date date-type="preprint" iso-8601-date="2026-07-30" publication-format="electronic"><day>30</day><month>07</month><year>2026</year></pub-date><history><date date-type="received" iso-8601-date="2026-07-17"><day>17</day><month>07</month><year>2026</year></date><date date-type="accepted" iso-8601-date="2026-07-30"><day>30</day><month>07</month><year>2026</year></date></history><permissions><copyright-statement xml:lang="en">Copyright ©; , Eco-Vector</copyright-statement><copyright-statement xml:lang="ru">Copyright ©; , Эко-Вектор</copyright-statement><copyright-statement xml:lang="zh">Copyright ©; ,</copyright-statement><copyright-holder xml:lang="en">Eco-Vector</copyright-holder><copyright-holder xml:lang="ru">Эко-Вектор</copyright-holder><license><ali:license_ref xmlns:ali="http://www.niso.org/schemas/ali/1.0/">https://eco-vector.com/for_authors.php#07</ali:license_ref></license></permissions><self-uri xlink:href="https://journals.eco-vector.com/RMMArep/article/view/716543">https://journals.eco-vector.com/RMMArep/article/view/716543</self-uri><abstract xml:lang="en"><p><bold>BACKGROUND:</bold> Cognitive impairment is common but poorly studied in patients with chronic kidney disease, particularly with end-stage renal disease.</p> <p><bold>AIM:</bold> Study to assess the prevalence clinical and demographic risk factors for cognitive impairment in patients receiving maintenance hemodialysis.</p> <p><bold>METHODS</bold>: A cross-sectional, multicenter study was completed with 260 patients aged 18 to 80 years receiving hemodialysis for six months and more. Cognitive functions were using the Montreal Cognitive Assessment (MoCA) and Mini-Mental State Examination (MMCE) scales. Participants were divided into two groups: with cognitive impairment and with normal cognitive function. The relationship between cognitive impairment with clinical and demographic parameters was studied using intergroup comparisons and multivariate logistic regression analysis.</p> <p><bold>RESULTS:</bold> The prevalence of cognitive impairment according to the MoCA scale was 63,5%, according to the MMCE scale – 60,1%. The most common changes were delayed in memory, visual-constructive and executive skills, orientation, attention, and speech. Age, diabetes mellitus, higher systolic blood pressure, elevated C-reactive protein and parathyroid hormone levels were identified as significant independent predictors of cognitive impairment (MoCA&lt;26 points) in patients on maintenance hemodialysis.</p> <p><bold>CONCLUSION:</bold> The obtained results confirm the high prevalence of multimodal cognitive disorders in patients on maintenance dialysis and substantiate the need for regular cognitive screening. Early detection of cognitive impairment and correction of modifiable risk factors can help preserve cognitive function, improve quality of life and prognosis in these patients.</p></abstract><trans-abstract xml:lang="ru"><p><bold>Обоснование</bold>. Когнитивные расстройства являются часто встречающимся, но мало изученным, состоянием у больных хронической болезнью почек, особенно в ее терминальной стадии.</p> <p><bold>Цель исследования</bold>. Изучить распространенность, характер и клинико-демографические факторы риска когнитивных расстройств у больных на программном гемодиализе.</p> <p><bold>Методы.</bold> Проведено кросс-секционное многоцентровое исследование с участием 260 больных в возрасте от 18 до 80 лет, получающих лечение программным гемодиализом в течение шести или более месяцев. Когнитивные функции оценивались с помощью шкал MоСА (Montreal Cognitive Assessment) и MMCE (Mini-Mental State Examination). Участники были разделены на две группы: с когнитивными расстройствами и с нормальными когнитивными функциями. Взаимосвязь когнитивных расстройств с основными клинико-демографическими параметрами изучалась с помощью межгрупповых сравнений и многофакторного логистического регрессионного анализа.</p> <p><bold>Результаты.</bold> Распространенность когнитивных расстройств по шкале MoCA составила 63,5%, по шкале ММСЕ – 60,1%. Наиболее часто изменения обнаруживались в области отсроченной памяти, зрительно-конструктивных и исполнительных навыков, ориентации, внимания и речи. Возраст, наличие сахарного диабета, более высокий уровень систолического артериального давления, повышенная концентрация в крови С-реактивного белка и паратгормона были идентифицированы как значимые независимые предикторы когнитивных расстройств (МоСА˂26 баллов) у пациентов на программном гемодиализе.</p> <p><bold>Заключение.</bold> Полученные результаты подтверждают широкую распространённость мультимодальных когнитивных расстройств у больных на программном гемодиализе и обосновывает необходимость регулярного когнитивного скрининга. Своевременное выявление когнитивных расстройств и коррекция модифицируемых факторов риска могут помочь сохранить когнитивные функции, улучшить качество жизни и прогноз этих больных.</p></trans-abstract><trans-abstract xml:lang="zh"><p/></trans-abstract><kwd-group xml:lang="en"><kwd>cognitive impairment, maintenance hemodialysis, age, systolic blood pressure, diabetes mellitus, C-reactive protein, parathyroid hormone.</kwd></kwd-group><kwd-group xml:lang="ru"><kwd>когнитивные расстройства, гемодиализ, возраст, систолическое артериальное давление, сахарный диабет, С-реактивный белок, паратгормон.</kwd></kwd-group><funding-group/></article-meta></front><body></body><back><ref-list><ref id="B1"><label>1.</label><mixed-citation>1. Bronas UG, Puzantian H, Hannan M. Cognitive Impairment in Chronic Kidney Disease: Vascular Milieu and the Potential Therapeutic Role of Exercise. Biomed Res Int. 2017;2017:1-10. doi: 10.1155/2017/2726369.</mixed-citation></ref><ref id="B2"><label>2.</label><mixed-citation>2. Kelly DM, Rothwell PM. Disentangling the Relationship Between Chronic Kidney Disease and Cognitive Disorders. Front Neurol. 2022;13:830064. doi: 10.3389/fneur.2022.830064.</mixed-citation></ref><ref id="B3"><label>3.</label><mixed-citation>3. Khrulev AЕ, Tolbuzova DD, Plokhenko EA, et al. Cognitive Status and Risk Factors for Cognitive Impairment in Dialysis Patients. General Reanimatology. 2020;16(4):21-31. doi: 10.15360/1813-9779-2020-4-21-31.</mixed-citation></ref><ref id="B4"><label>4.</label><mixed-citation>4. Mobushar JA, Shahzad A, et al. Prevalence and Pattern of Cognitive Impairment in Patients on Maintenance Hemodialysis. Cureus. 2025;17(5):e84649. doi: 10.7759/cureus.84649.</mixed-citation></ref><ref id="B5"><label>5.</label><mixed-citation>5. Tian R, Guo Y, Ye P, et al. The validation of the Beijing version of the Montreal Cognitive Assessment in Chinese patients undergoing hemodialysis. PLoS One. 2020;15(1):e0227073. doi: 10.1371/journal.pone.0227073.</mixed-citation></ref><ref id="B6"><label>6.</label><mixed-citation>6. Zhang J, Wu L, Wang P, et al. Prevalence of cognitive impairment and its predictors among chronic kidney disease patients: A systematic review and meta-analysis. PLoS One. 2024;19(6):e0304762. doi: 10.1371/journal.pone.0304762.</mixed-citation></ref><ref id="B7"><label>7.</label><mixed-citation>7. Wang K, Echeagaray AR, Campbell SM, et al. The Diagnostic Performance of Screening Instruments for Mild Cognitive Impairment and Dementia in Chronic Kidney Disease and Kidney Failure: A Systematic Review and Meta-analysis. Kidney Med. 2025;7(8):101037. doi: 10.1016/j.xkme.2025.101037.</mixed-citation></ref><ref id="B8"><label>8.</label><mixed-citation>8. Ткачева О.Н., Яхно Н.Н., Незнанов Н.Г. и др. Клинические рекомендации «Когнитивные расстройства у лиц пожилого и старческого возраста». Журнал неврологии и психиатрии им. С.С. Корсакова. 2025;125(3‑3):7‑149. doi: 10.17116/jnevro2025125337. EDN PHCDMH.</mixed-citation></ref><ref id="B9"><label>9.</label><mixed-citation>9. Емелин А.Ю., Лобзин В.Ю. Начальные признаки когнитивных нарушений: определение, критерии диагностики. Журнал неврологии и психиатрии им. С.С. Корсакова. Спецвыпуски. 2026;126(4‑2):23‑28. doi: 10.17116/jnevro202612604223. EDN JDZRLP.</mixed-citation></ref><ref id="B10"><label>10.</label><mixed-citation>10. van Zwieten A, Wong G, Ruospo M, et al. COGNITIVE-HD study investigators. Prevalence and patterns of cognitive impairment in adult hemodialysis patients: the COGNITIVE-HD study. Nephrol Dial Transplant. 2018;33(7):1197-1206. doi: 10.1093/ndt/gfx314.</mixed-citation></ref><ref id="B11"><label>11.</label><mixed-citation>11. O'Lone E, Connors M, Masson P, et al. Cognition in People With End-Stage Kidney Disease Treated With Hemodialysis: A Systematic Review and Meta-analysis. Am J Kidney Dis. 2016;67(6):925-35. doi: 10.1053/j.ajkd.2015.12.028.</mixed-citation></ref><ref id="B12"><label>12.</label><mixed-citation>12. Schorr M, Zalitach M, House C, Gomes J, et al. Cognitive Impairment Early After Initiating Maintenance Hemodialysis: A Cross Sectional Study. Front Neurol. 2022;13:719208. doi: 10.3389/fneur.2022.719208.</mixed-citation></ref><ref id="B13"><label>13.</label><mixed-citation>13. Chan FHF, Newman S, Khan BA, et al. The role of subjective cognitive complaints in self-management among haemodialysis patients: a cross-sectional study. BMC Nephrol. 2022;23(1):363. doi: 10.1186/s12882-022-02994-2.</mixed-citation></ref><ref id="B14"><label>14.</label><mixed-citation>14. Hannan M, Steffen A, Quinn L, et al. The assessment of cognitive function in older adult patients with chronic kidney disease: an integrative review. J Nephrol. 2019;32(2):211-230. doi: 10.1007/s40620-018-0494-2.</mixed-citation></ref><ref id="B15"><label>15.</label><mixed-citation>15. Карселадзе Н.Д., Евдокимов Ф.А., Старокожева А.Я. Роль нарушений микроциркуляции в развитии когнитивных нарушений у пациентов с артериальной гипертонией. Вестник Российской Военно-медицинской академии. 2019;S3:70-72. EDN: FHZJCG.</mixed-citation></ref><ref id="B16"><label>16.</label><mixed-citation>16. Ромашевский Б.В., Салухов В.В., Максим О.В., и др. Патогенетические аспекты развития деменции у больных сахарным диабетом 2-го типа. Вестник Российской военно-медицинской академии. 2025;27(1):105–114. doi: 10.17816/brmma630664.</mixed-citation></ref><ref id="B17"><label>17.</label><mixed-citation>17.Williamson JD, Pajewski NM, Auchus AP, et al. Effect of Intensive vs Standard Blood Pressure Control on Probable Dementia: A Randomized Clinical Trial. JAMA. 2019;321(6):553-561. doi: 10.1001/jama.2018.21442.</mixed-citation></ref><ref id="B18"><label>18.</label><mixed-citation>18. Rotondi S, Tartaglione L, Pasquali M, et al. Association between Cognitive Impairment and Malnutrition in Hemodialysis Patients: Two Sides of the Same Coin. Nutrients. 2023;15(4):813. doi: 10.3390/nu15040813.</mixed-citation></ref><ref id="B19"><label>19.</label><mixed-citation>19. Gong X, Zou L, Wu H, Shan Y, et al. Altered brain structural and cognitive impairment in end-stage renal disease patients with secondary hyperparathyroidism. Acta Radiol. 2020;61(6):796-803. doi: 10.1177/0284185119878360.</mixed-citation></ref><ref id="B20"><label>20.</label><mixed-citation>20. Smogorzewski MJ, Massry SG. Altered acetylcholine metabolism of brain in uremia: role of secondary hyperparathyroidism. J Ren Nutr. 2008;18(1):122-6. doi: 10.1053/j.jrn.2007.10.025.</mixed-citation></ref><ref id="B21"><label>21.</label><mixed-citation>21. Mekhora C, Lamport DJ, Spencer JPE. An overview of the relationship between inflammation and cognitive function in humans, molecular pathways and the impact of nutraceuticals. Neurochem Int. 2024;181:105900. doi: 10.1016/j.neuint.2024.105900.</mixed-citation></ref><ref id="B22"><label>22.</label><mixed-citation>22. Pyatchenkov MO, Kudryavtsev IV, Shсherbakov EV, et al. Immunomodulatory effects of gut bacterial metabolites in patients on maintenance hemodialysis. Medical &amp; pharmaceutical journal “Pulse”. 2025;27(8):36-44. doi: 10.26787/nydha-2686-6838-2025-27-8-36-44.</mixed-citation></ref><ref id="B23"><label>23.</label><mixed-citation>23. Pyatchenkov MO, Vlasov AA, Sherbakov EV, et al. Microbial-Derived Uremic Toxins: Role in the Pathogenesis of Comorbidities in Patients with Chronic Kidney Disease. Russian Journal of Gastroenterology, Hepatology, Coloproctology. 2023;33(3):7-15. doi: 10.22416/1382-4376-2023-33-3-7-15.</mixed-citation></ref></ref-list></back></article>
